We are live on
!
Find out more
XT
XTX Topco Portfolio holdings
AUM
$5.75B
1-Year Est. Return
30.56%
This Fund
S&P 500
This Quarter
Est. Return
+3.96%
1 Year Est. Return
+30.56%
3 Year Est. Return
+70.38%
5 Year Est. Return
+43.83%
10 Year Est. Return
–
AUM
$477M
AUM Growth
+$5.92M
(+1.3%)
Cap. Flow
+$16M
Cap. Flow
% of AUM
3.36%
Top 10 Holdings %
Top 10 Hldgs %
4.53%
Holding
1,805
New
734
Increased
232
Reduced
251
Closed
586
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Estee Lauder
EL
|
+$1.93M |
| 2 |
Paychex
PAYX
|
+$1.88M |
| 3 |
Burlington
BURL
|
+$1.87M |
| 4 |
Constellation Brands
STZ
|
+$1.83M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$1.79M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$3.28M |
| 2 |
AT&T
T
|
+$2.32M |
| 3 |
Walt Disney
DIS
|
+$2.27M |
| 4 |
Apple
AAPL
|
+$2.21M |
| 5 |
Honeywell
HON
|
+$2.17M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.32% |
| 2 | Healthcare | 16.05% |
| 3 | Consumer Discretionary | 12.91% |
| 4 | Industrials | 12.34% |
| 5 | Financials | 12.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
CytomX Therapeutics
CTMX
$708M
| $26.9K | 0.01% |
17,815
-11,762
| -40% | -$26.6K |
|
|
AFMD
1202
DELISTED
Affimed
AFMD
| $26.8K | 0.01% |
+3,600
| New | +$36K |
|
|
SURF
1203
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $26.5K | 0.01% |
37,874
-145,705
| -79% | -$118K |
|
|
TRVG
1204
trivago
TRVG
$382M
| $23.7K | 0.01% |
+3,137
| New | +$25.7K |
|
|
UXIN
1205
Uxin Ltd
UXIN
$354M
| $22.9K | ﹤0.01% |
+1,024
| New | +$30.1K |
|
1206
Absci
ABSI
$1.28B
| $22.9K | ﹤0.01% |
13,088
-18,343
| -58% | -$44.4K |
|
|
CKPT
1207
DELISTED
Checkpoint Therapeutics
CKPT
| $22.8K | ﹤0.01% |
+10,125
| New | +$50.8K |
|
|
SHCR
1208
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $22K | ﹤0.01% |
+15,516
| New | +$35.2K |
|
1209
ProQR Therapeutics
PRQR
$244M
| $21.6K | ﹤0.01% |
+10,160
| New | +$31.1K |
|
1210
Standard BioTools
LAB
$303M
| $21K | ﹤0.01% |
10,744
-25,886
| -71% | -$51.1K |
|
|
DPRO
1211
Draganfly
DPRO
$162M
| $20.5K | ﹤0.01% |
+642
| New | +$26.5K |
|
1212
FingerMotion
FNGR
$16.6M
| $18.7K | ﹤0.01% |
12,457
-3,069
| -20% | -$7.82K |
|
|
BETS
1213
DELISTED
Bit Brother Limited Class A Ordinary Shares
BETS
| $18.5K | ﹤0.01% |
+22
| New | +$67.1K |
|
1214
Genius Group
GNS
$31.7M
| $17.1K | ﹤0.01% |
+1,267
| New | +$43.2K |
|
|
MSPRW
1215
DELISTED
MSP Recovery Inc Warrant
MSPRW
| $17.1K | ﹤0.01% |
858,922
| – | – |
|
1216
Magic Empire Global Ltd
MEGL
$6.09M
| $15.5K | ﹤0.01% |
+2,533
| New | +$20.2K |
|
|
AEVA
1217
Aeva Technologies
AEVA
$1.06B
| $13.4K | ﹤0.01% |
+2,252
| New | +$18.1K |
|
|
TGI
1218
DELISTED
Triumph Group
TGI
| $6.6K | ﹤0.01% |
13,325
-12,982
| -49% | -$148K |
|
1219
Agilent Technologies
A
$38.9B
| – | – |
-1,547
| Closed | -$232K |
|
1220
Applied Optoelectronics
AAOI
$7.85B
| – | – |
-33,530
| Closed | -$63.4K |
|
|
1221
Apple
AAPL
$4.95T
| – | – |
-17,014
| Closed | -$2.21M |
|
1222
AbbVie
ABBV
$454B
| – | – |
-2,752
| Closed | -$445K |
|
1223
Abeona Therapeutics
ABEO
$349M
| – | – |
-51,888
| Closed | -$160K |
|
1224
ProFrac Holding
ACDC
$725M
| – | – |
-15,867
| Closed | -$400K |
|
1225
Acadia Healthcare
ACHC
$2.99B
| – | – |
-6,776
| Closed | -$558K |
|
Similar funds
HW
AAM
RWM
SAM
PP
VH
TSW
KIM
XTX Topco's Q1 2023 Portfolio in Review
As of Q1 2023, XTX Topco held 1,805 positions worth $477M, up 1.3% from $471M the previous quarter. Its ten largest holdings account for 4.5% of the portfolio.
XTX Topco deployed $16M of net new capital in Q1 2023, opening 734 new positions and adding to 232 existing holdings. Its largest new stake was Estee Lauder: 7,582 shares worth $1.87M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $3.28M trimmed.
- XTX Topco's largest Q1 2023 buy was Estee Lauder: 7,582 shares worth $1.87M.
- XTX Topco added most to Regeneron Pharmaceuticals in Q1 2023, an estimated $1.79M increase.
- XTX Topco's biggest Q1 2023 reduction was Alphabet (Google) Class A, cutting an estimated $3.28M.
- XTX Topco fully exited Apple in Q1 2023, selling an estimated $2.21M.
- XTX Topco's ten largest holdings make up 4.5% of its $477M portfolio in Q1 2023.
- XTX Topco opened 734 new positions and closed 586 in Q1 2023.
- XTX Topco's portfolio value rose 1.3% quarter-over-quarter to $477M.
Based on XTX Topco's 13F filing for Q1 2023, filed 12 May 2023.